Northern Trust Corp Tandem Diabetes Care Inc Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Northern Trust Corp holds 635,688 shares of TNDM stock, worth $19.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
635,688
Previous 364,544 74.38%
Holding current value
$19.2 Million
Previous $14.7 Million 83.52%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$35.21 - $47.3 $9.55 Million - $12.8 Million
271,144 Added 74.38%
635,688 $27 Million
Q2 2024

Aug 14, 2024
BUY
$30.43 - $53.43 $670,038 - $1.18 Million
22,019 Added 6.43%
364,544 $14.7 Million
Q1 2024

May 14, 2024
SELL
$22.09 - $35.41 $183,324 - $293,867
-8,299 Reduced 2.37%
342,525 $12.1 Million
Q4 2023

Feb 13, 2024
SELL
$14.28 - $31.03 $372,208 - $808,796
-26,065 Reduced 6.92%
350,824 $10.4 Million
Q3 2023

Nov 13, 2023
BUY
$19.33 - $36.22 $154,871 - $290,194
8,012 Added 2.17%
376,889 $7.83 Million
Q2 2023

Aug 11, 2023
BUY
$24.18 - $42.46 $114,589 - $201,217
4,739 Added 1.3%
368,877 $9.05 Million
Q1 2023

May 15, 2023
SELL
$35.86 - $46.5 $8.33 Million - $10.8 Million
-232,280 Reduced 38.95%
364,138 $14.8 Million
Q4 2022

Feb 13, 2023
SELL
$35.49 - $56.15 $270,398 - $427,806
-7,619 Reduced 1.26%
596,418 $26.8 Million
Q3 2022

Nov 14, 2022
BUY
$43.76 - $68.97 $5.83 Million - $9.19 Million
133,290 Added 28.31%
604,037 $28.9 Million
Q2 2022

Aug 12, 2022
SELL
$53.22 - $123.09 $692,924 - $1.6 Million
-13,020 Reduced 2.69%
470,747 $27.9 Million
Q1 2022

May 13, 2022
SELL
$101.89 - $150.09 $934,942 - $1.38 Million
-9,176 Reduced 1.86%
483,767 $56.3 Million
Q4 2021

Feb 08, 2022
BUY
$118.18 - $153.21 $400,393 - $519,075
3,388 Added 0.69%
492,943 $74.2 Million
Q3 2021

Nov 15, 2021
BUY
$93.51 - $129.4 $18.4 Million - $25.5 Million
196,716 Added 67.18%
489,555 $58.4 Million
Q2 2021

Aug 13, 2021
SELL
$77.0 - $100.19 $653,037 - $849,711
-8,481 Reduced 2.81%
292,839 $28.5 Million
Q1 2021

May 12, 2021
BUY
$81.28 - $104.34 $526,531 - $675,914
6,478 Added 2.2%
301,320 $26.6 Million
Q4 2020

Feb 11, 2021
BUY
$86.4 - $121.75 $21,513 - $30,315
249 Added 0.08%
294,842 $28.2 Million
Q3 2020

Nov 16, 2020
SELL
$95.43 - $116.09 $80,733 - $98,212
-846 Reduced 0.29%
294,593 $33.4 Million
Q2 2020

Aug 14, 2020
SELL
$60.05 - $98.92 $25.3 Million - $41.7 Million
-421,102 Reduced 58.77%
295,439 $29.2 Million
Q1 2020

May 14, 2020
BUY
$47.37 - $90.04 $512,069 - $973,332
10,810 Added 1.53%
716,541 $46.1 Million
Q4 2019

Feb 14, 2020
SELL
$53.13 - $71.19 $1.11 Million - $1.49 Million
-20,864 Reduced 2.87%
705,731 $42.1 Million
Q3 2019

Nov 13, 2019
BUY
$57.11 - $73.3 $3.12 Million - $4.01 Million
54,639 Added 8.13%
726,595 $42.9 Million
Q2 2019

Aug 13, 2019
BUY
$54.41 - $71.7 $439,360 - $578,977
8,075 Added 1.22%
671,956 $43.4 Million
Q1 2019

May 13, 2019
BUY
$32.25 - $73.56 $63,242 - $144,251
1,961 Added 0.3%
663,881 $42.2 Million
Q4 2018

Feb 12, 2019
BUY
$28.45 - $40.65 $589,313 - $842,024
20,714 Added 3.23%
661,920 $25.1 Million
Q3 2018

Nov 14, 2018
BUY
$21.39 - $51.17 $2.31 Million - $5.53 Million
108,145 Added 20.29%
641,206 $27.5 Million
Q2 2018

Sep 18, 2018
BUY
$4.9 - $23.64 $94,702 - $456,890
19,327 Added 3.76%
533,061 $11.7 Million
Q2 2018

Aug 14, 2018
BUY
$4.9 - $23.64 $2.11 Million - $10.2 Million
429,987 Added 513.44%
513,734 $11.3 Million
Q1 2018

May 09, 2018
BUY
$2.35 - $4.96 $196,805 - $415,385
83,747 New
83,747 $415,000

Others Institutions Holding TNDM

# of Institutions
360
Shares Held
72.5M
Call Options Held
3.36M
Put Options Held
229K
View Full List

About TANDEM DIABETES CARE INC

TNDM Quotes by TradingView
  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.94B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email